Xue LA - Search Results

1

The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7.

Vinall RL, Tepper CG, Shi XB, Xue LA, Gandour-Edwards R, de Vere White RW. Vinall RL, et al. Among authors: xue la. Oncogene. 2006 Mar 30;25(14):2082-93. doi: 10.1038/sj.onc.1209246. Oncogene. 2006. PMID: 16434975

2

Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.

Yang P, Guo L, Duan ZJ, Tepper CG, Xue L, Chen X, Kung HJ, Gao AC, Zou JX, Chen HW. Yang P, et al. Mol Cell Biol. 2012 Aug;32(15):3121-31. doi: 10.1128/MCB.00204-12. Epub 2012 May 29. Mol Cell Biol. 2012. PMID: 22645312 Free PMC article.

3

DIM stimulates IFNgamma gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways.

Xue L, Firestone GL, Bjeldanes LF. Xue L, et al. Oncogene. 2005 Mar 31;24(14):2343-53. doi: 10.1038/sj.onc.1208434. Oncogene. 2005. PMID: 15735741

4

Expression and regulation of a molecular marker, SPR1, in multistep bronchial carcinogenesis.

Lau D, Xue L, Hu R, Liaw T, Wu R, Reddy S. Lau D, et al. Am J Respir Cell Mol Biol. 2000 Jan;22(1):92-6. doi: 10.1165/ajrcmb.22.1.3637. Am J Respir Cell Mol Biol. 2000. PMID: 10615070

5

Is inhibition of cancer angiogenesis and growth by paclitaxel schedule dependent?

Lau D, Guo L, Gandara D, Young LJ, Xue L. Lau D, et al. Anticancer Drugs. 2004 Oct;15(9):871-5. doi: 10.1097/00001813-200410000-00007. Anticancer Drugs. 2004. PMID: 15457127

6

Paclitaxel (Taxol): an inhibitor of angiogenesis in a highly vascularized transgenic breast cancer.

Lau DH, Xue L, Young LJ, Burke PA, Cheung AT. Lau DH, et al. Cancer Biother Radiopharm. 1999 Feb;14(1):31-6. doi: 10.1089/cbr.1999.14.31. Cancer Biother Radiopharm. 1999. PMID: 10850285

7

Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice.

Xue L, Nolla H, Suzuki A, Mak TW, Winoto A. Xue L, et al. Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2022-7. doi: 10.1073/pnas.0712059105. Epub 2008 Feb 4. Proc Natl Acad Sci U S A. 2008. PMID: 18250301 Free PMC article.

8

The role of the PI3K-AKT kinase pathway in T-cell development beyond the beta checkpoint.

Xue L, Chiang L, Kang C, Winoto A. Xue L, et al. Eur J Immunol. 2008 Nov;38(11):3200-7. doi: 10.1002/eji.200838614. Eur J Immunol. 2008. PMID: 18991293 Free PMC article.

9

Coupling of the cell cycle and apoptotic machineries in developing T cells.

Xue L, Sun Y, Chiang L, He B, Kang C, Nolla H, Winoto A. Xue L, et al. J Biol Chem. 2010 Mar 5;285(10):7556-65. doi: 10.1074/jbc.M109.035535. Epub 2010 Jan 12. J Biol Chem. 2010. PMID: 20068041 Free PMC article.

10

Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis.

Osborn SL, Diehl G, Han SJ, Xue L, Kurd N, Hsieh K, Cado D, Robey EA, Winoto A. Osborn SL, et al. Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13034-9. doi: 10.1073/pnas.1005997107. Epub 2010 Jul 6. Proc Natl Acad Sci U S A. 2010. PMID: 20615958 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters